BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 15151661)

  • 21. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.
    Molhoek SG; Bax JJ; van Erven L; Bootsma M; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Apr; 93(7):860-3. PubMed ID: 15050489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
    Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
    Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
    Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
    Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy in heart failure.
    Auricchio A; Fantoni C
    Ital Heart J; 2005 Mar; 6(3):256-60. PubMed ID: 15875517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-pharmacological therapy of decompensated heart failure: cardiac resynchronization therapy].
    Storti C; Longobardi M; Buzzi MP; Negro MC; Pilun EB; Baldi A; Falcone C
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):123S-128S. PubMed ID: 19195320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.
    Davis DR; Krahn AD; Tang AS; Lemery R; Green MS; Gollob M; Yee R; Skanes AC; Klein GJ; Birnie DH
    Can J Cardiol; 2005 Apr; 21(5):413-7. PubMed ID: 15861258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-millisecond interventricular difference as assessed by body surface potential mapping identifies patients with clinical improvement after implantation of cardiac resynchronization device.
    Samesima N; Douglas R; Tobias N; Pedrosa A; Martinelli Filho M; Ramires JA; Pastore CA
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():213-5. PubMed ID: 17584728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden of atrial fibrillation after cardiac resynchronization therapy.
    Adelstein EC; Saba S
    Am J Cardiol; 2007 Jul; 100(2):268-72. PubMed ID: 17631081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of response to cardiac resynchronization therapy--importance of left ventricular dyssynchrony.
    Santos JF; Parreira L; Madeira J; Seixo F; Mendes L; Lopes C; Venâncio J; Lourenço J; Caetano F; Inês L; Mendes M
    Rev Port Cardiol; 2006 Jun; 25(6):569-81. PubMed ID: 17019976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
    Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
    Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
    Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
    J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
    Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
    Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.